EUROPEAN JOURNAL OF THERAPEUTICS, vol.23, no.3, pp.106-110, 2017 (ESCI)
Article / Article
EUROPEAN JOURNAL OF THERAPEUTICS
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Lymphoma, autologous hematopoietic stem cell transplantation, non-malignant, late effect, BONE-MARROW-TRANSPLANTATION, HIGH-DOSE CHEMOTHERAPY, COMPLICATIONS, CHILDHOOD, SURVIVORS, HODGKIN, ADULTS
Eskisehir Osmangazi University Affiliated:
Objective: Developments in transplantation procedures have led to an increase in the number of long-term survivors after hematopoietic stem cell transplantation (HSCT). In this study, we investigated non-malignant late side effects after autologous HSCT (AHSCT) in lymphoma patients.